These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1197260)

  • 41. The effects of varying dialysis regimens on lymphocyte stimulation.
    Hurst KS; Saldanha LF; Steinberg SM; Galen MA; Lowrie EG; Gagneux SA; Lazarus JM; Strom TB; Carpenter CB; Merrill JP
    Trans Am Soc Artif Intern Organs; 1975; 21():329-34. PubMed ID: 1146004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abnormal lipoprotein in uraemic patients treated conservatively and by maintenance haemodialysis.
    Alam SM; Bhatt AK
    J Assoc Physicians India; 1991 Feb; 39(2):170-1. PubMed ID: 1885478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurological manifestations of uraemia and chronic dialysis.
    Tzamaloukas AH; Agaba EI
    Niger J Med; 2004; 13(2):98-105. PubMed ID: 15293824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Influence of haemodialysis on cellular immunodeficiency in uraemic patients (author's transl)].
    Reis HE; Heimsoth VH; Hirche H; Eitelhuber U
    Klin Wochenschr; 1974 May; 52(9):437-43. PubMed ID: 4409847
    [No Abstract]   [Full Text] [Related]  

  • 45. The immune status of the uremic patient: hemodialysis vs CAPD.
    Schollmeyer P; Bozkurt F
    Clin Nephrol; 1988; 30 Suppl 1():S37-40. PubMed ID: 3052959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Uremia as a state of immune deficiency.
    Birkeland SA
    Scand J Immunol; 1976; 5(1-2):107-15. PubMed ID: 131369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of zinc supplementation on zinc status and immunity in haemodialysis patients.
    Kouw PM; Konings CH; de Vries PM; van der Meulen J; Oe PL
    J Trace Elem Electrolytes Health Dis; 1991 Jun; 5(2):115-9. PubMed ID: 1821709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppressor cell activity of peripheral mononuclear cells from patients undergoing chronic haemodialysis.
    Guillou PJ; Woodhouse LF; Davison AM; Giles GR
    Biomedicine; 1980 Feb; 32(1):11-7. PubMed ID: 6445213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The course of autonomic neural function in chronic uraemic patients during haemodialysis treatment.
    Vita G; Savica V; Puglisi RM; Marabello L; Bellinghieri G; Messina C
    Nephrol Dial Transplant; 1992; 7(10):1022-5. PubMed ID: 1331877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of haemodialysis on insulin requirements in uraemic diabetic patients. Studies with the artificial beta-cell.
    Schmitz O
    Proc Eur Dial Transplant Assoc; 1983; 19():769-72. PubMed ID: 6348766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunological studies in uremic and kidney transplanted patients.
    Langhoff E
    Dan Med Bull; 1989 Apr; 36(2):160-75. PubMed ID: 2651030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative losses of free amino acids and their plasma variations in artificial substitutive programmes for chronic uraemia.
    Scolari MP; Stefoni S; Mosconi G; Feliciangeli G; Colì L; Bonomini V
    Life Support Syst; 1983; 1(1):51-60. PubMed ID: 6678371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defective immune and phagocytic functions in uraemia and renal transplantation.
    McIntosh J; Hansen P; Ziegler J; Penny R
    Int Arch Allergy Appl Immunol; 1976; 51(5):544-59. PubMed ID: 786902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphocytotoxins and mixed leucocyte culture blocking factor activity in the plasma of uraemic patients undergoing haemodialysis.
    Sengar DP; Rashid A; Perelmutter L; Harris JE
    Clin Exp Immunol; 1975 May; 20(2):249-55. PubMed ID: 129310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma endothelin levels in patients with uraemia.
    Koyama H; Tabata T; Nishzawa Y; Inoue T; Morii H; Yamaji T
    Lancet; 1989 May; 1(8645):991-2. PubMed ID: 2565518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low levels of dehydroascorbic acid in uraemic serum and the partial correction of dehydroascorbic acid deficiency by haemodialysis.
    Bakaev VV; Efremov AV; Tityaev II
    Nephrol Dial Transplant; 1999 Jun; 14(6):1472-4. PubMed ID: 10383010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are uraemic children immunologically compromised?
    Ensari C; Ekim M; Ikinciogullari A; Tümer N; Ensari A
    Nephron; 2001 Aug; 88(4):379-81. PubMed ID: 11474235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor VIII complex in uraemia and effects of haemodialysis.
    Turney JH; Woods HF; Fewell MR; Weston MJ
    Br Med J (Clin Res Ed); 1981 May; 282(6277):1653-6. PubMed ID: 6786417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of serum and plasma from hemodialysis patients on the lymphoproliferative response.
    Miyakoshi H; Aoki T; Hirasawa Y
    Clin Nephrol; 1979 Dec; 12(6):263-8. PubMed ID: 527279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.